Goldman Sachs
BLFS icon

Goldman Sachs’s BioLife Solutions BLFS Stock Holding History

Goldman Sachs’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
+37,500
New +$876K ﹤0.01% 5168

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs's BLFS Position: Q2 2026 in Review

Goldman Sachs increased its BioLife Solutions (BLFS) stake by 100% in Q2 2026, buying an estimated $6.22M and bringing the position to 531,582 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #2908.

Goldman Sachs first reported a position in BLFS in Q1 2019 and has held it in 28 quarters since. The position peaked at $39M in Q4 2023. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Goldman Sachs held 531,582 shares of BioLife Solutions worth $15M as of Q2 2026.
  • Goldman Sachs bought 266,095 BioLife Solutions shares in Q2 2026, an estimated $6.22M.
  • BioLife Solutions made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2908 holding.
  • Goldman Sachs first reported a position in BioLife Solutions in Q1 2019 and has held it in 28 quarters since.
  • Goldman Sachs's BioLife Solutions position peaked at $39M in Q4 2023.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.